Featured Research

from universities, journals, and other organizations

Researchers closer to understanding actions of cells involved in atherosclerosis

Date:
September 10, 2012
Source:
St. Michael's Hospital
Summary:
Researchers are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

The clue might be something called microRNA-145. MicroRNAs are short chains of bossy molecules that scientists are increasingly coming to realize control a wide variety of biological processes.

Dr. Subodh Verma, a cardiac surgeon at St. Michael's, published a paper in the journal Circulation September 10, describing for the first time how microRNA-145 gene therapy can drastically reduce the severity and progression of atherosclerosis in mice.

In addition this approach appeared to make the atherosclerotic plaque more stable and less prone to burst.

Atherosclerosis, commonly called hardening of the arteries, is a condition in which fat, cholesterol and other substances build up in the walls of arteries and form hard structures called plaques. It is the leading cause of death in Canada.

Dr. Verma said most heart attacks occur when plaques rupture like a broken eggshell and release their contents into the artery. Researchers are therefore looking for ways to reduce the size of plaques and make them more stable.

One of the key questions is what causes the outer layer of the plaque to finally burst -- a layer of smooth muscle cells known as the fibrous cap. These cells undergo "phenotypic transformation" in response to various stressful environments and cardiovascular risk factors, making them more likely to rupture and cause heart attacks. MicroRNA-145 is one of the factors that appear to play a critical role in preventing the transformation of vascular smooth muscle cells into rupture-prone cells.

In atherosclerosis-prone animals, microRNA-145-based gene therapy reduced the plaque size by approximately 50 per cent and increased the collagen content of the plaque and fibrous cap area by 40 to 50 per cent, indicating that this therapy can reduce plaque buildup and also make it less prone to rupture, the inciting event of heart attacks.

The researchers also found that in human atherosclerotic plaques, the amount of microRNA-145 was reduced compared to normal arteries that were free of plaque, providing supporting human insights to the animal study.

"Atherosclerosis continues to be the number one killer in modern societies and finding new ways to treat this problem are needed," said Dr. Verma.

Dr. Fina Lovren, a senior research associate at St Michael's Hospital, carried out the experimental work on this project under the direction of Dr. Verma.


Story Source:

The above story is based on materials provided by St. Michael's Hospital. The original article was written by Leslie Shepherd. Note: Materials may be edited for content and length.


Journal Reference:

  1. F. Lovren, Y. Pan, A. Quan, K. K. Singh, P. C. Shukla, N. Gupta, B. M. Steer, A. J. Ingram, M. Gupta, M. Al-Omran, H. Teoh, P. A. Marsden, S. Verma. MicroRNA-145 Targeted Therapy Reduces Atherosclerosis. Circulation, 2012; 126 (11_suppl_1): S81 DOI: 10.1161/CIRCULATIONAHA.111.084186

Cite This Page:

St. Michael's Hospital. "Researchers closer to understanding actions of cells involved in atherosclerosis." ScienceDaily. ScienceDaily, 10 September 2012. <www.sciencedaily.com/releases/2012/09/120910185759.htm>.
St. Michael's Hospital. (2012, September 10). Researchers closer to understanding actions of cells involved in atherosclerosis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/09/120910185759.htm
St. Michael's Hospital. "Researchers closer to understanding actions of cells involved in atherosclerosis." ScienceDaily. www.sciencedaily.com/releases/2012/09/120910185759.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins